Showing results (101-110 of 196) with videos related to

Sort By:
Pageof 20
BMC Nephrology|May 1, 2015
What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?Seamus Kent, Iryna Schlackow, Jingky Lozano-Kühne, et al.
Pharmacoeconomics|February 24, 2023
Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UKJunwen Zhou, Runguo Wu, Claire Williams, et al.
Thrombosis and Haemostasis|July 22, 2016
Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurementGiovanna Petrucci, Alessandro Rizzi, Viviana Cavalca, et al.
Experimental Hematology|October 27, 2004
Modulation of the expression and activity of cyclooxygenases in normal and accelerated erythropoiesisBianca Rocca, Paola Secchiero, Claudio Celeghini, et al.
Health Technology Assessment (Winchester, England)|December 7, 2024
Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data setsBorislava Mihaylova, Runguo Wu, Junwen Zhou, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 23, 2016
Effect of Processing Delay and Storage Conditions on Urine Albumin-to-Creatinine RatioWilliam Herrington, Nicola Illingworth, Natalie Staplin, et al.
The Lancet Regional Health. Europe|March 29, 2024
Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling studyBorislava Mihaylova, Runguo Wu, Junwen Zhou, et al.
Heart (British Cardiac Society)|September 10, 2024
Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling studyBorislava Mihaylova, Runguo Wu, Junwen Zhou, et al.
The New England Journal of Medicine|November 13, 2009
Revascularization versus medical therapy for renal-artery stenosis, Keith Wheatley, Natalie Ives, et al.
Clinical Kidney Journal|September 9, 2020
Erratum: The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY studyWilliam G Herrington, David Preiss, Richard Haynes, et al.
Pageof 20